Compare · country
China
vs India.
India and China are Asia's two dominant medical tourism markets. India leads on absolute price, English fluency at top private hospitals, and cardiac surgery; China leads on advanced regenerative medicine, oncology technology (proton, CAR-T), and procedural volume.
Verdict
The bottom line.
Choose India for cardiac surgery, IVF, complex paediatrics, and cost-conscious orthopedics. Choose China for regenerative medicine (stem cell, exosome), CAR-T, proton therapy, integrative TCM, and procedural volume.
Side-by-side
China vs India, by the numbers.
Verdict markers (↑) indicate where the listed option has a clear advantage based on aggregate evidence and pricing as of 2024–2025. Individual cases vary — request a personalized assessment for your specific situation.
FAQ
China vs India, answered.
- Is India cheaper than China for medical tourism?
- For most procedures, India is 10–20% cheaper than China on absolute price. The exceptions are advanced regenerative medicine (China's NMPA-regulated cellular therapy), CAR-T (Chinese pricing ~⅓ of Indian), and proton therapy (China has 8 clinical centres vs India's 1).
- Which is better for cardiac surgery — China or India?
- Indian top private hospitals (Narayana, Apollo, Fortis) are global benchmarks for cardiac surgery volume and cost — particularly CABG and valve replacement. Chinese centres (Fuwai, Shanghai Ruijin) match on technology and outcomes but are 15–25% more expensive. For cardiac surgery, India is typically the recommended destination.
- Which has better English support?
- India — top private hospitals (Apollo, Fortis, Max, Medanta) operate fully in English with native-speaker physicians. Chinese international medical departments offer English-speaking coordinators and physicians, but native fluency is rarer outside Hong Kong-affiliated facilities like HKU-Shenzhen.
Related guides
All Top Destinations
Compare 8 leading medical tourism countries side-by-side.
Read moreProton Therapy in China
8 clinical centres including Shanghai and Wuwei.
Read moreCAR-T Therapy in China
4 NMPA-approved products at one-third US pricing.
Read moreChina vs Thailand
Where China leads vs Thailand for medical tourism in 2026
Read comparisonChina vs Turkey
China vs Turkey for medical tourism — specialties, cost and accreditation
Read comparisonNeed a personalized
recommendation?
The verdict above is general. Send your case and we’ll return a personalized recommendation — destination, hospital, treatment plan and itemized quote — in 5 business days.